盆腔器官脱垂和压力性尿失禁经阴道重建术后的疼痛与活动能力
这项2×2析因随机试验的预设二次分析纳入374例接受经阴道自体组织重建术加顶端悬吊及尿道中段吊带术的患者,比较宫骶韧带与骶棘韧带悬吊。术后疼痛短暂轻度升高后于4-6周降至基线以下,功能活动持续改善至2年,两组间多数结局无差异。
要点
- 术后2周静息和日常活动疼痛较基线轻度升高,3个月降至基线以下,两组无差异。
- 功能活动评分在4-6周和3个月较基线改善,SF-36疼痛和躯体功能等量表改善持续至24个月。
- 宫骶韧带悬吊组术后4-6周新发或加重新臀部疼痛少于骶棘韧带组(4.6% vs 10.5%,P=0.043)。
核心结论
- 对于2-4期盆腔器官脱垂,经阴道自体组织重建术加宫骶韧带或骶棘韧带阴道顶端悬吊及尿道中段吊带术后,疼痛和功能活动改善可持续至2年。
- 术后即刻疼痛平均较轻,至4-6周改善至基线以下水平。
研究设计与样本
- 这是一项2×2析因随机试验的预设二次分析,纳入2008年至2013年在9个医疗中心随机接受宫骶韧带(n=188)或骶棘韧带(n=186)阴道顶端悬吊的374例女性,同时治疗2-4期阴道顶端脱垂和压力性尿失禁。
- 参与者还被随机分配接受围手术期盆底肌治疗或常规护理;所有患者均接受经阴道自体组织修补和尿道中段吊带术。
主要发现
- 术前静息和日常活动平均疼痛(校正均数±标准误)分别为2.24±0.23和2.76±0.25;术后2周分别较基线升高0.65(P=0.004)和0.74(P=0.007),3个月分别较基线降低0.87和1.14(P<0.001),手术组间无差异。
- 运动/剧烈活动时疼痛和最严重疼痛在4-6周较基线降低1.26(P=0.014)和0.95(P=0.002),3个月降低1.97和1.50(P<0.001),手术组间无差异。
- 活动评估量表评分在4-6周较基线改善9.24(P<0.001),3个月改善13.79(P<0.001)。
- MOS 36项简表健康调查的躯体疼痛、躯体功能和角色-躯体量表在6、12和24个月较基线显著改善(24个月分别改善5.62、5.79和4.72,P均<0.001),组间无差异。
- 宫骶韧带悬吊组术后4-6周新发或加重新臀部疼痛少于骶棘韧带悬吊组(4.6% vs 10.5%,P=0.043),腹股沟或大腿疼痛无差异。
关键数值与推荐
- 术前使用麻醉性止痛药者占14.3%,术后2周为53.7%,4-6周为26.1%,此后与基线相似,至24个月降至6.8%。
- 术前使用非麻醉性止痛药者占48.1%,术后2周为68.7%,3个月与基线相似,此后稳步下降至2年时的26.6%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about short- and long-term pain and functional activity after surgery for pelvic organ prolapse. OBJECTIVE: The objectives of the study were to describe postoperative pain and functional activity after transvaginal native tissue reconstructive surgery with apical suspension and retropubic synthetic midurethral sling and to compare these outcomes between patients receiving 2 common transvaginal prolapse repairs, uterosacral ligament, and sacrospinous ligament vaginal vault suspension. STUDY DESIGN: This planned secondary analysis of a 2 × 2 factorial randomized trial included 374 women randomized to receive uterosacral (n = 188) or sacrospinous (n = 186) vaginal vault suspension to treat both stages 2-4 apical vaginal prolapse and stress urinary incontinence between 2008 and 2013 at 9 medical centers. Participants were also randomized to receive perioperative pelvic muscle therapy or usual care. All patients received transvaginal native tissue repairs and a midurethral sling. Participants completed the Surgical Pain Scales (0-10 numeric rating scales; higher scores = greater pain) and Activity Assessment Scale (0-100; higher score = higher activity) prior to surgery and at 2 weeks, 4-6 weeks, and 3 months postoperatively. The MOS 36-item Short-Form Health Survey was completed at baseline and 6, 12, and 24 months after surgery; the bodily pain, physical functioning, and role-physical subscales were used for this analysis (higher scores = less disability). Self-reported pain medication use was also collected. RESULTS: Before surgery, average pain at rest and during normal activity were (adjusted mean ± SE) 2.24 ± 0.23 and 2.76 ± 0.25; both increased slightly from baseline at 2 weeks (+0.65, P = .004, and +0.74, P = .007, respectively) and then decreased below baseline at 3 months (-0.87 and -1.14, respectively, P < .001), with no differences between surgical groups. Pain during exercise/strenuous activity and worst pain decreased below baseline levels at 4-6 weeks (-1.26, P = .014, and -0.95, P = .002) and 3 months (-1.97 and -1.50, P < .001) without differences between surgical groups. Functional activity as measured by the Activity Assessment Scale improved from baseline at 4-6 weeks (+9.24, P < .001) and 3 months (+13.79, P < .001). The MOS 36-item Short-Form Health Survey Bodily Pain, Physical Functioning, and Role-Physical Scales demonstrated significant improvements from baseline at 6, 12, and 24 months (24 months: +5.62, +5.79, and +4.72, respectively, P < .001 for each) with no differences between groups. Use of narcotic pain medications was reported by 14.3% of participants prior to surgery and 53.7% at 2 and 26.1% at 4-6 weeks postoperatively; thereafter use was similar to baseline rates until 24 months when it decreased to 6.8%. Use of nonnarcotic pain medication was reported by 48.1% of participants prior to surgery, 68.7% at 2 weeks, and similar to baseline at 3 months; thereafter use dropped steadily to 26.6% at 2 years. Uterosacral ligament suspension resulted in less new or worsening buttock pain than sacrospinous suspension at 4-6 weeks postoperatively (4.6% vs 10.5%, P = .043) but no difference in groin or thigh pain. CONCLUSION: Pain and functional activity improve for up to 2 years after native tissue reconstructive surgery with uterosacral or sacrospinous vaginal vault suspension and midurethral sling for stages 2-4 pelvic organ prolapse. On average, immediate postoperative pain is low and improves to below baseline levels by 4-6 weeks.
引用
- Barber MD, Brubaker L, Nygaard I, et al. Pain and activity after vaginal reconstructive surgery for pelvic organ prolapse and stress urinary incontinence. Am J Obstet Gynecol. 2019. PMID: 31201809. doi:10.1016/j.ajog.2019.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。